BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Doan TN, Eisen DP, Rose MT, Slack A, Stearnes G, McBryde ES. Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis. PLoS One 2017;12:e0188631. [PMID: 29182688 DOI: 10.1371/journal.pone.0188631] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Khabibullina NF, Kutuzova DM, Burmistrova IA, Lyadova IV. The Biological and Clinical Aspects of a Latent Tuberculosis Infection. TropicalMed 2022;7:48. [DOI: 10.3390/tropicalmed7030048] [Reference Citation Analysis]
2 Hamaguchi Y, Yamaguchi T, Nishiura H. Estimating the annual risk of tuberculosis infection in Japan from interferon-gamma release assay data. J Theor Biol 2019;460:125-33. [PMID: 30315813 DOI: 10.1016/j.jtbi.2018.10.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wigg AJ, Narayana SK, Anwar S, Ramachandran J, Muller K, Chen JW, John L, Hissaria P, Kaambwa B, Woodman RJ. High rates of indeterminate interferon‐gamma release assays for the diagnosis of latent tuberculosis infection in liver transplantation candidates. Transpl Infect Dis 2019;21:e13087. [DOI: 10.1111/tid.13087] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
4 Chandrasekaran P, Mave V, Thiruvengadam K, Gupte N, Shivakumar SVBY, Hanna LE, Kulkarni V, Kadam D, Dhanasekaran K, Paradkar M, Thomas B, Kohli R, Dolla C, Bharadwaj R, Sivaramakrishnan GN, Pradhan N, Gupte A, Murali L, Valvi C, Swaminathan S, Gupta A; CTRIUMPH Study Team. Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting. PLoS One 2018;13:e0199360. [PMID: 30067752 DOI: 10.1371/journal.pone.0199360] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
5 Zhang L, Wan S, Zhou Z, Zhang Y, Liu X. Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot study. BMC Infect Dis 2021;21:651. [PMID: 34225667 DOI: 10.1186/s12879-021-06351-w] [Reference Citation Analysis]
6 Corbière V, Segers J, Desmet R, Lecher S, Loyens M, Petit E, Melnyk O, Locht C, Mascart F. Natural T Cell Epitope Containing Methyl Lysines on Mycobacterial Heparin-Binding Hemagglutinin. J Immunol 2020;204:1715-23. [PMID: 32122997 DOI: 10.4049/jimmunol.1901214] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Gupta S, Kakkar V. Recent technological advancements in tuberculosis diagnostics - A review. Biosens Bioelectron 2018;115:14-29. [PMID: 29783081 DOI: 10.1016/j.bios.2018.05.017] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
8 Rana A, Thakur S, Kumar G, Akhter Y. Recent Trends in System-Scale Integrative Approaches for Discovering Protective Antigens Against Mycobacterial Pathogens. Front Genet 2018;9:572. [PMID: 30538722 DOI: 10.3389/fgene.2018.00572] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
9 Li K, Yang C, Jiang Z, Liu S, Liu J, Fan C, Li T, Dong X. Quantitative investigation of factors relevant to the T cell spot test for tuberculosis infection in active tuberculosis. BMC Infect Dis 2019;19:673. [PMID: 31357953 DOI: 10.1186/s12879-019-4310-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Godfrey MS, Friedman LN. Tuberculosis and Biologic Therapies: Anti-Tumor Necrosis Factor-α and Beyond. Clin Chest Med 2019;40:721-39. [PMID: 31731980 DOI: 10.1016/j.ccm.2019.07.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
11 Oliveira-Cortez A, Froede EL, Cristine de Melo A, Sant'Anna CC, Pinto LA, Mauricio da Rocha EM, Di Lorenzo Oliveira C, Camargos P. Low Prevalence of Latent Tuberculosis Infection among Contacts of Smear-Positive Adults in Brazil. Am J Trop Med Hyg 2019;101:1077-82. [PMID: 31482780 DOI: 10.4269/ajtmh.19-0100] [Reference Citation Analysis]
12 Adams S, Ehrlich R, Baatjies R, Dendukuri N, Wang Z, Dheda K. Evaluating Latent Tuberculosis Infection Test Performance Using Latent Class Analysis in a TB and HIV Endemic Setting. Int J Environ Res Public Health 2019;16:E2912. [PMID: 31416206 DOI: 10.3390/ijerph16162912] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Afonso A, Pires B, Teixeira C, Nogueira A. Tuberculin Skin Testing versus Interferon-Gamma Release Assay among Users of a Public Health Unit in Northeast Portugal. Port J Public Health. [DOI: 10.1159/000514875] [Reference Citation Analysis]
14 Liu Q, Lu P, Martinez L, Peng H, Zhu T, Zhu L, Wang J, Lu W. Undiagnosed diabetes mellitus and tuberculosis infection: A population-based, observational study from eastern China. Diabetes Metab Res Rev 2020;36:e3227. [PMID: 31655015 DOI: 10.1002/dmrr.3227] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Hasan T, Au E, Chen S, Tong A, Wong G. Screening and prevention for latent tuberculosis in immunosuppressed patients at risk for tuberculosis: a systematic review of clinical practice guidelines. BMJ Open 2018;8:e022445. [PMID: 30209157 DOI: 10.1136/bmjopen-2018-022445] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
16 Szturmowicz M, Broniarek-Samson B, Demkow U. Prevalence and risk factors for latent tuberculosis in polish healthcare workers: the comparison of tuberculin skin test and interferon-gamma release assay (IGRA) performance. J Occup Med Toxicol 2021;16:38. [PMID: 34470622 DOI: 10.1186/s12995-021-00326-y] [Reference Citation Analysis]
17 Cuadros EN, Calzada-Hernández J, Clemente D, Martín SG, Silveira LF, Lirola-Cruz MJ, Tagarro A, Lovillo MC, Rueda RMA, López AL, Aritziturri MS, Calvo C. Position statement of the Spanish Society of Pediatric Rheumatology on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies: Part 1 (screening). Eur J Pediatr 2022. [PMID: 35258699 DOI: 10.1007/s00431-022-04418-7] [Reference Citation Analysis]
18 Dreesman A, Dirix V, Smits K, Corbière V, Van Praet A, Debulpaep S, De Schutter I, Felderhof MK, Malfroot A, Singh M, Locht C, Mouchet F, Mascart F. Identification of Mycobacterium tuberculosis Infection in Infants and Children With Partial Discrimination Between Active Disease and Asymptomatic Infection. Front Pediatr 2019;7:311. [PMID: 31404140 DOI: 10.3389/fped.2019.00311] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Hannech E, Boussaid S, Rekik S, Jemmali S, Ajlani H, Cheour E, Sahli H, Elleuch M. Multifocal tuberculosis on certolizumab pegol in a patient followed for rheumatoid arthritis. Clin Case Rep 2021;9:e04307. [PMID: 34136240 DOI: 10.1002/ccr3.4307] [Reference Citation Analysis]
20 Moran E, Baharani J, Dedicoat M, Robinson E, Smith G, Bhomra P, Thien OS, Ryan R. Risk factors associated with the development of active tuberculosis among patients with advanced chronic kidney disease. J Infect 2018;77:291-5. [PMID: 29928915 DOI: 10.1016/j.jinf.2018.06.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
21 De Maertelaere E, Vandendriessche S, Verhasselt B, Coorevits L, André E, Padalko E, Boelens J, Land GA. Evaluation of QuantiFERON-TB Gold Plus on Liaison XL in a Low-Tuberculosis-Incidence Setting. J Clin Microbiol 2020;58. [DOI: 10.1128/jcm.00159-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
22 Dirix V, Dauby N, Hites M, Watelet E, Van Praet A, Godefroid A, Petit E, Singh M, Locht C, Mascart F, Corbière V, Turenne CY. Optimal Detection of Latent Mycobacterium tuberculosis Infection by Combined Heparin-Binding Hemagglutinin (HBHA) and Early Secreted Antigenic Target 6 (ESAT-6) Whole-Blood Interferon Gamma Release Assays. J Clin Microbiol. [DOI: 10.1128/jcm.02443-21] [Reference Citation Analysis]
23 Erawati M, Andriany M. The Prevalence and Demographic Risk Factors for Latent Tuberculosis Infection (LTBI) Among Healthcare Workers in Semarang, Indonesia. J Multidiscip Healthc 2020;13:197-206. [PMID: 32110034 DOI: 10.2147/JMDH.S241972] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
24 Shang X, Wang L, Liu Y, Liu X, Lv J, Zhou X, Wang H, Nazierhan S, Wang J, Ma X. Diagnostic value of CXCR3 and its ligands in spinal tuberculosis. Exp Ther Med 2021;21:73. [PMID: 33365073 DOI: 10.3892/etm.2020.9505] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Chung J, Aronson AB, Srikantha R, Vogelgesang SA, Wanat KA. Low conversion rate of QuantiFERON-TB Gold screening tests in patients treated with tumor necrosis factor inhibitors: A retrospective cohort study identifying an important practice gap. J Am Acad Dermatol 2018;79:169-71. [PMID: 29588247 DOI: 10.1016/j.jaad.2018.03.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
26 Dreesman A, Corbière V, Libin M, Racapé J, Collart P, Singh M, Locht C, Mascart F, Dirix V. Specific Host Signatures for the Detection of Tuberculosis Infection in Children in a Low TB Incidence Country. Front Immunol 2021;12:575519. [PMID: 33790886 DOI: 10.3389/fimmu.2021.575519] [Reference Citation Analysis]
27 Tong X, Li Z, Zhao J, Liu S, Fan H. The value of single or combined use of pleural fluid interferon gamma release assay in the diagnosis of tuberculous pleurisy. Trop Med Int Health 2021. [PMID: 34297877 DOI: 10.1111/tmi.13659] [Reference Citation Analysis]
28 Kim TY, Chang HE, Lee SW, Seo SH, Hong YJ, Park JS, Park KU. A novel strategy for interpreting the T-SPOT.TB test results read by an ELISPOT plate imager. PLoS One 2019;14:e0222920. [PMID: 31553764 DOI: 10.1371/journal.pone.0222920] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Woldu HG, Zalwango S, Martinez L, Castellanos ME, Kakaire R, Sekandi JN, Kiwanuka N, Whalen CC. Defining an intermediate category of tuberculin skin test: A mixture model analysis of two high-risk populations from Kampala, Uganda. PLoS One 2021;16:e0245328. [PMID: 33481816 DOI: 10.1371/journal.pone.0245328] [Reference Citation Analysis]
30 Benhadou F, Dirix V, Domont F, Willaert F, Van Praet A, Locht C, Mascart F, Corbière V. Tuberculosis Risk Stratification of Psoriatic Patients Before Anti-TNF-α Treatment. Front Immunol 2021;12:672894. [PMID: 34149708 DOI: 10.3389/fimmu.2021.672894] [Reference Citation Analysis]
31 Stek C, Buyze J, Menten J, Schutz C, Thienemann F, Blumenthal L, Maartens G, Boyles T, Wilkinson RJ, Meintjes G, Lynen L. Diagnostic Accuracy of the INSHI Consensus Case Definition for the Diagnosis of Paradoxical Tuberculosis-IRIS. J Acquir Immune Defic Syndr 2021;86:587-92. [PMID: 33394813 DOI: 10.1097/QAI.0000000000002606] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Chen H, Nakagawa A, Takamori M, Abe S, Ueno D, Horita N, Kato S, Seki N. Diagnostic accuracy of the interferon-gamma release assay in acquired immunodeficiency syndrome patients with suspected tuberculosis infection: a meta-analysis. Infection. [DOI: 10.1007/s15010-022-01789-9] [Reference Citation Analysis]
33 Yang P, Chen Z, Zhang J, Li W, Zhu C, Qiu P, Quan Y, Cui X, Yuan L, Jiang C. Evaluation of Varicella-zoster virus-specific cell-mediated immunity by interferon-γ Enzyme-Linked Immunosorbent Assay in adults ≥50 years of age administered a herpes zoster vaccine. J Med Virol 2019;91:829-35. [PMID: 30613990 DOI: 10.1002/jmv.25391] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]